APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biolayer Interferometry (BLI)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biolayer Interferometry (BLI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026196 pages

Choose your research edition.

Industry ResearchBiolayer Interferometry (BLI) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Biolayer Interferometry (BLI) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biolayer Interferometry (BLI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biolayer Interferometry (BLI) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Biolayer Interferometry (BLI) Market Analysis and Forecast 2026-2032229 pages · $4,950 USD

Market perspective

The global Biolayer Interferometry (BLI) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biolayer Interferometry (BLI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biolayer Interferometry (BLI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biolayer Interferometry (BLI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biolayer Interferometry (BLI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biolayer Interferometry (BLI) include Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biolayer Interferometry (BLI) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biolayer Interferometry (BLI) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biolayer Interferometry (BLI) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biolayer Interferometry (BLI) market size, projected growth trends, production technologies, key applications, and end-use industries.

Biolayer Interferometry (BLI) Segment by Company

Ichor Life Sciences, Inc

Creative BioMart

GenScript

ROCKLAND IMMUNOCHEMICALS, INC

BPS Bioscience, Inc

Creative Proteomics

Creative Biostructure

Profacgen

Creative Biolabs

Biocult

KMD Bioscience Co., Ltd

Biolayer Interferometry (BLI) Segment by Type

Affinity and Kinetic Analysis

Drug and Antibody Screening

Drug and Antibody Discovery

Protein Quantification

Others

Biolayer Interferometry (BLI) Segment by Application

Pharmaceutical Industry

Diagnostics

Biotechnology

Scientific Research

Others

Biolayer Interferometry (BLI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biolayer Interferometry (BLI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biolayer Interferometry (BLI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biolayer Interferometry (BLI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biolayer Interferometry (BLI) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biolayer Interferometry (BLI) industry.

Chapter 3: Detailed analysis of Biolayer Interferometry (BLI) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biolayer Interferometry (BLI)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Affinity and Kinetic Analysis Table 3. Key Players of Drug and Antibody Screening Table 4. Key Players of Drug and Antibody Discovery Table 3. Key Players of Protein Quantification Table 4. Key Players of Others Table 5. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Pharmaceutical Industry Table 7. Key Players of Diagnostics Table 8. Key Players of Biotechnology Table 9. Key Players of Scientific Research Table 10. Key Players of Others Table 11. Global Biolayer Interferometry (BLI) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Biolayer Interferometry (BLI) Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Biolayer Interferometry (BLI) Market Share by Region (2021-2026) Table 14. Global Biolayer Interferometry (BLI) Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Biolayer Interferometry (BLI) Market Share by Region (2027-2032) Table 16. Biolayer Interferometry (BLI) Industry Trends Table 17. Biolayer Interferometry (BLI) Industry Drivers Table 18. Biolayer Interferometry (BLI) Industry Opportunities and Challenges Table 19. Biolayer Interferometry (BLI) Industry Restraints Table 20. Global Biolayer Interferometry (BLI) Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Biolayer Interferometry (BLI) Revenue Market Share by Company (2021-2026) Table 22. Global Biolayer Interferometry (BLI) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Biolayer Interferometry (BLI) Key Company Head Office and Area Served Table 24. Global Biolayer Interferometry (BLI) Company, Product Type & Application Table 25. Global Biolayer Interferometry (BLI) Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Biolayer Interferometry (BLI) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Biolayer Interferometry (BLI) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biolayer Interferometry (BLI) Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Biolayer Interferometry (BLI) Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2021-2026) Table 32. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2027-2032) Table 33. Global Biolayer Interferometry (BLI) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biolayer Interferometry (BLI) Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Biolayer Interferometry (BLI) Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2021-2026) Table 37. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2027-2032) Table 38. Ichor Life Sciences, Inc Company Information Table 39. Ichor Life Sciences, Inc Business Overview Table 40. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Portfolio Table 42. Ichor Life Sciences, Inc Recent Development Table 43. Creative BioMart Company Information Table 44. Creative BioMart Business Overview Table 45. Creative BioMart Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Creative BioMart Biolayer Interferometry (BLI) Product Portfolio Table 47. Creative BioMart Recent Development Table 48. GenScript Company Information Table 49. GenScript Business Overview Table 50. GenScript Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. GenScript Biolayer Interferometry (BLI) Product Portfolio Table 52. GenScript Recent Development Table 53. ROCKLAND IMMUNOCHEMICALS, INC Company Information Table 54. ROCKLAND IMMUNOCHEMICALS, INC Business Overview Table 55. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Portfolio Table 57. ROCKLAND IMMUNOCHEMICALS, INC Recent Development Table 58. BPS Bioscience, Inc Company Information Table 59. BPS Bioscience, Inc Business Overview Table 60. BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Portfolio Table 62. BPS Bioscience, Inc Recent Development Table 63. Creative Proteomics Company Information Table 64. Creative Proteomics Business Overview Table 65. Creative Proteomics Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Creative Proteomics Biolayer Interferometry (BLI) Product Portfolio Table 67. Creative Proteomics Recent Development Table 68. Creative Biostructure Company Information Table 69. Creative Biostructure Business Overview Table 70. Creative Biostructure Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Creative Biostructure Biolayer Interferometry (BLI) Product Portfolio Table 72. Creative Biostructure Recent Development Table 73. Profacgen Company Information Table 74. Profacgen Business Overview Table 75. Profacgen Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Profacgen Biolayer Interferometry (BLI) Product Portfolio Table 77. Profacgen Recent Development Table 78. Creative Biolabs Company Information Table 79. Creative Biolabs Business Overview Table 80. Creative Biolabs Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Creative Biolabs Biolayer Interferometry (BLI) Product Portfolio Table 82. Creative Biolabs Recent Development Table 83. Biocult Company Information Table 84. Biocult Business Overview Table 85. Biocult Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Biocult Biolayer Interferometry (BLI) Product Portfolio Table 87. Biocult Recent Development Table 88. KMD Bioscience Co., Ltd Company Information Table 89. KMD Bioscience Co., Ltd Business Overview Table 90. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Portfolio Table 92. KMD Bioscience Co., Ltd Recent Development Table 93. North America Biolayer Interferometry (BLI) Market Size by Type (2021-2026) & (US$ Million) Table 94. North America Biolayer Interferometry (BLI) Market Size by Type (2027-2032) & (US$ Million) Table 95. North America Biolayer Interferometry (BLI) Market Size by Application (2021-2026) & (US$ Million) Table 96. North America Biolayer Interferometry (BLI) Market Size by Application (2027-2032) & (US$ Million) Table 97. North America Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Biolayer Interferometry (BLI) Market Size by Country (2021-2026) Table 99. North America Biolayer Interferometry (BLI) Market Size by Country (2027-2032) Table 100. Europe Biolayer Interferometry (BLI) Market Size by Type (2021-2026) & (US$ Million) Table 101. Europe Biolayer Interferometry (BLI) Market Size by Type (2027-2032) & (US$ Million) Table 102. Europe Biolayer Interferometry (BLI) Market Size by Application (2021-2026) & (US$ Million) Table 103. Europe Biolayer Interferometry (BLI) Market Size by Application (2027-2032) & (US$ Million) Table 104. Europe Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Biolayer Interferometry (BLI) Market Size by Country (2021-2026) Table 106. Europe Biolayer Interferometry (BLI) Market Size by Country (2027-2032) Table 107. China Biolayer Interferometry (BLI) Market Size by Type (2021-2026) & (US$ Million) Table 108. China Biolayer Interferometry (BLI) Market Size by Type (2027-2032) & (US$ Million) Table 109. China Biolayer Interferometry (BLI) Market Size by Application (2021-2026) & (US$ Million) Table 110. China Biolayer Interferometry (BLI) Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Biolayer Interferometry (BLI) Market Size by Type (2021-2026) & (US$ Million) Table 112. Asia Biolayer Interferometry (BLI) Market Size by Type (2027-2032) & (US$ Million) Table 113. Asia Biolayer Interferometry (BLI) Market Size by Application (2021-2026) & (US$ Million) Table 114. Asia Biolayer Interferometry (BLI) Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Asia Biolayer Interferometry (BLI) Market Size by Country (2021-2026) Table 117. Asia Biolayer Interferometry (BLI) Market Size by Country (2027-2032) Table 118. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Type (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Type (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Application (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Application (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021-2026) Table 124. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2027-2032) Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Biolayer Interferometry (BLI) Product Image Figure 2. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biolayer Interferometry (BLI) Market Share by Type: 2025 VS 2032 Figure 4. Affinity and Kinetic Analysis Image Figure 5. Drug and Antibody Screening Image Figure 6. Drug and Antibody Discovery Image Figure 7. Protein Quantification Image Figure 8. Others Image Figure 9. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Biolayer Interferometry (BLI) Market Share by Application: 2025 VS 2032 Figure 11. Pharmaceutical Industry Image Figure 12. Diagnostics Image Figure 13. Biotechnology Image Figure 14. Scientific Research Image Figure 15. Others Image Figure 16. Global Biolayer Interferometry (BLI) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 18. Global Biolayer Interferometry (BLI) Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Biolayer Interferometry (BLI) Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Biolayer Interferometry (BLI) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Biolayer Interferometry (BLI) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2021-2032) Figure 25. Global Biolayer Interferometry (BLI) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2021-2032) Figure 27. North America Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 28. North America Biolayer Interferometry (BLI) Market Share by Type (2021-2032) Figure 29. North America Biolayer Interferometry (BLI) Market Share by Application (2021-2032) Figure 30. North America Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 31. United States Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 32. Canada Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 34. Europe Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 35. Europe Biolayer Interferometry (BLI) Market Share by Type (2021-2032) Figure 36. Europe Biolayer Interferometry (BLI) Market Share by Application (2021-2032) Figure 37. Europe Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 38. Germany Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 39. France Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 41. Italy Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 42. Russia Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 44. China Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 45. China Biolayer Interferometry (BLI) Market Share by Type (2021-2032) Figure 46. China Biolayer Interferometry (BLI) Market Share by Application (2021-2032) Figure 47. Asia Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 48. Asia Biolayer Interferometry (BLI) Market Share by Type (2021-2032) Figure 49. Asia Biolayer Interferometry (BLI) Market Share by Application (2021-2032) Figure 50. Asia Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 51. Japan Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 55. India Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 56. Australia Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Biolayer Interferometry (BLI) Market Share by Country (2021-2032) Figure 61. Brazil Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 66. UAE Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 68. Chile Biolayer Interferometry (BLI) Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Affinity and Kinetic Analysis
  • Drug and Antibody Screening
  • Drug and Antibody Discovery
  • Protein Quantification
  • Others
Applications
  • Pharmaceutical Industry
  • Diagnostics
  • Biotechnology
  • Scientific Research
  • Others
Companies covered
  • Ichor Life Sciences, Inc
  • Creative BioMart
  • GenScript
  • ROCKLAND IMMUNOCHEMICALS, INC
  • BPS Bioscience, Inc
  • Creative Proteomics
  • Creative Biostructure
  • Profacgen
  • Creative Biolabs
  • Biocult
  • KMD Bioscience Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Affinity and Kinetic Analysis
  5. 1.2.3 Drug and Antibody Screening
  6. 1.2.4 Drug and Antibody Discovery
  7. 1.2.5 Protein Quantification
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Biolayer Interferometry (BLI) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceutical Industry
  12. 1.3.3 Diagnostics
  13. 1.3.4 Biotechnology
  14. 1.3.5 Scientific Research
  15. 1.3.6 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Biolayer Interferometry (BLI) Growth Trends by Region
  18. 1.5.1 Global Biolayer Interferometry (BLI) Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Biolayer Interferometry (BLI) Market Size by Region (2021-2026)
  20. 1.5.3 Biolayer Interferometry (BLI) Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Biolayer Interferometry (BLI) Market Dynamics
  1. 2.1 Biolayer Interferometry (BLI) Industry Trends
  2. 2.2 Biolayer Interferometry (BLI) Industry Drivers
  3. 2.3 Biolayer Interferometry (BLI) Industry Opportunities and Challenges
  4. 2.4 Biolayer Interferometry (BLI) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biolayer Interferometry (BLI) Revenue by Company (2021-2026)
  2. 3.2 Global Biolayer Interferometry (BLI) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biolayer Interferometry (BLI) Key Company Head office and Area Served
  4. 3.4 Global Biolayer Interferometry (BLI) Company, Product Type & Application
  5. 3.5 Global Biolayer Interferometry (BLI) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biolayer Interferometry (BLI) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biolayer Interferometry (BLI) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biolayer Interferometry (BLI) Tier 1, Tier 2, and Tier 3
4 Biolayer Interferometry (BLI) Market by Type
  1. 4.1 Global Biolayer Interferometry (BLI) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biolayer Interferometry (BLI) Market Size by Type (2021-2032)
  3. 4.3 Global Biolayer Interferometry (BLI) Market Size Share by Type (2021-2032)
5 Biolayer Interferometry (BLI) Market by Application
  1. 5.1 Global Biolayer Interferometry (BLI) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biolayer Interferometry (BLI) Market Size by Application (2021-2032)
  3. 5.3 Global Biolayer Interferometry (BLI) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Ichor Life Sciences, Inc
  2. 6.1.1 Ichor Life Sciences, Inc Company Information
  3. 6.1.2 Ichor Life Sciences, Inc Business Overview
  4. 6.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Portfolio
  6. 6.1.5 Ichor Life Sciences, Inc Recent Developments
  7. 6.2 Creative BioMart
  8. 6.2.1 Creative BioMart Company Information
  9. 6.2.2 Creative BioMart Business Overview
  10. 6.2.3 Creative BioMart Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Creative BioMart Biolayer Interferometry (BLI) Product Portfolio
  12. 6.2.5 Creative BioMart Recent Developments
  13. 6.3 GenScript
  14. 6.3.1 GenScript Company Information
  15. 6.3.2 GenScript Business Overview
  16. 6.3.3 GenScript Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GenScript Biolayer Interferometry (BLI) Product Portfolio
  18. 6.3.5 GenScript Recent Developments
  19. 6.4 ROCKLAND IMMUNOCHEMICALS, INC
  20. 6.4.1 ROCKLAND IMMUNOCHEMICALS, INC Company Information
  21. 6.4.2 ROCKLAND IMMUNOCHEMICALS, INC Business Overview
  22. 6.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Portfolio
  24. 6.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Developments
  25. 6.5 BPS Bioscience, Inc
  26. 6.5.1 BPS Bioscience, Inc Company Information
  27. 6.5.2 BPS Bioscience, Inc Business Overview
  28. 6.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Portfolio
  30. 6.5.5 BPS Bioscience, Inc Recent Developments
  31. 6.6 Creative Proteomics
  32. 6.6.1 Creative Proteomics Company Information
  33. 6.6.2 Creative Proteomics Business Overview
  34. 6.6.3 Creative Proteomics Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Creative Proteomics Biolayer Interferometry (BLI) Product Portfolio
  36. 6.6.5 Creative Proteomics Recent Developments
  37. 6.7 Creative Biostructure
  38. 6.7.1 Creative Biostructure Company Information
  39. 6.7.2 Creative Biostructure Business Overview
  40. 6.7.3 Creative Biostructure Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Creative Biostructure Biolayer Interferometry (BLI) Product Portfolio
  42. 6.7.5 Creative Biostructure Recent Developments
  43. 6.8 Profacgen
  44. 6.8.1 Profacgen Company Information
  45. 6.8.2 Profacgen Business Overview
  46. 6.8.3 Profacgen Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Profacgen Biolayer Interferometry (BLI) Product Portfolio
  48. 6.8.5 Profacgen Recent Developments
  49. 6.9 Creative Biolabs
  50. 6.9.1 Creative Biolabs Company Information
  51. 6.9.2 Creative Biolabs Business Overview
  52. 6.9.3 Creative Biolabs Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Creative Biolabs Biolayer Interferometry (BLI) Product Portfolio
  54. 6.9.5 Creative Biolabs Recent Developments
  55. 6.10 Biocult
  56. 6.10.1 Biocult Company Information
  57. 6.10.2 Biocult Business Overview
  58. 6.10.3 Biocult Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Biocult Biolayer Interferometry (BLI) Product Portfolio
  60. 6.10.5 Biocult Recent Developments
  61. 6.11 KMD Bioscience Co., Ltd
  62. 6.11.1 KMD Bioscience Co., Ltd Company Information
  63. 6.11.2 KMD Bioscience Co., Ltd Business Overview
  64. 6.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Portfolio
  66. 6.11.5 KMD Bioscience Co., Ltd Recent Developments
7 North America
  1. 7.1 North America Biolayer Interferometry (BLI) Market Size (2021-2032)
  2. 7.2 North America Biolayer Interferometry (BLI) Market Size by Type
  3. 7.2.1 North America Biolayer Interferometry (BLI) Market Size by Type (2021-2026)
  4. 7.2.2 North America Biolayer Interferometry (BLI) Market Size by Type (2027-2032)
  5. 7.2.3 North America Biolayer Interferometry (BLI) Market Share by Type (2021-2032)
  6. 7.3 North America Biolayer Interferometry (BLI) Market Size by Application
  7. 7.3.1 North America Biolayer Interferometry (BLI) Market Size by Application (2021-2026)
  8. 7.3.2 North America Biolayer Interferometry (BLI) Market Size by Application (2027-2032)
  9. 7.3.3 North America Biolayer Interferometry (BLI) Market Share by Application (2021-2032)
  10. 7.4 North America Biolayer Interferometry (BLI) Market Size by Country
  11. 7.4.1 North America Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  13. 7.4.3 North America Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
  14. 7.4.4 North America Biolayer Interferometry (BLI) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biolayer Interferometry (BLI) Market Size (2021-2032)
  2. 8.2 Europe Biolayer Interferometry (BLI) Market Size by Type
  3. 8.2.1 Europe Biolayer Interferometry (BLI) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biolayer Interferometry (BLI) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biolayer Interferometry (BLI) Market Share by Type (2021-2032)
  6. 8.3 Europe Biolayer Interferometry (BLI) Market Size by Application
  7. 8.3.1 Europe Biolayer Interferometry (BLI) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biolayer Interferometry (BLI) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biolayer Interferometry (BLI) Market Share by Application (2021-2032)
  10. 8.4 Europe Biolayer Interferometry (BLI) Market Size by Country
  11. 8.4.1 Europe Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biolayer Interferometry (BLI) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biolayer Interferometry (BLI) Market Size (2021-2032)
  2. 9.2 China Biolayer Interferometry (BLI) Market Size by Type
  3. 9.2.1 China Biolayer Interferometry (BLI) Market Size by Type (2021-2026)
  4. 9.2.2 China Biolayer Interferometry (BLI) Market Size by Type (2027-2032)
  5. 9.2.3 China Biolayer Interferometry (BLI) Market Share by Type (2021-2032)
  6. 9.3 China Biolayer Interferometry (BLI) Market Size by Application
  7. 9.3.1 China Biolayer Interferometry (BLI) Market Size by Application (2021-2026)
  8. 9.3.2 China Biolayer Interferometry (BLI) Market Size by Application (2027-2032)
  9. 9.3.3 China Biolayer Interferometry (BLI) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biolayer Interferometry (BLI) Market Size (2021-2032)
  2. 10.2 Asia Biolayer Interferometry (BLI) Market Size by Type
  3. 10.2.1 Asia Biolayer Interferometry (BLI) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biolayer Interferometry (BLI) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biolayer Interferometry (BLI) Market Share by Type (2021-2032)
  6. 10.3 Asia Biolayer Interferometry (BLI) Market Size by Application
  7. 10.3.1 Asia Biolayer Interferometry (BLI) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biolayer Interferometry (BLI) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biolayer Interferometry (BLI) Market Share by Application (2021-2032)
  10. 10.4 Asia Biolayer Interferometry (BLI) Market Size by Country
  11. 10.4.1 Asia Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biolayer Interferometry (BLI) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biolayer Interferometry (BLI) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst